Super Large Bore Catheters for Stroke: How Bigger Devices Are Improving Thrombectomy Outcomes

What Are Super Large Bore Catheters and Why Do They Matter for Stroke?

Mechanical thrombectomy has become the standard of care for acute ischemic stroke caused by large vessel occlusion since landmark trials such as MR CLEAN, ESCAPE, and EXTEND-IA demonstrated its superiority over medical therapy alone. The procedure involves threading a catheter through the arterial system to the site of the clot in the brain and either aspirating it directly or retrieving it with a stent-like device. Over the past decade, device manufacturers have progressively increased catheter bore sizes to improve clot engagement and aspiration force.

A new systematic review published in the Journal of NeuroInterventional Surgery now examines the clinical evidence surrounding these super large bore aspiration catheters — generally defined as those with an inner diameter of 0.071 inches or greater. The review consolidates findings from multiple studies to assess whether the larger devices translate into meaningful improvements in recanalization success, procedural efficiency, and patient outcomes. This is particularly relevant as neurointerventionalists increasingly adopt direct aspiration first-pass technique (ADAPT) as a primary thrombectomy approach.

What Does the Systematic Review Show About Thrombectomy Success Rates?

First-pass effect — achieving successful recanalization with a single attempt — has emerged as an important quality metric in stroke intervention. Research has shown that patients who achieve recanalization on the first pass tend to have better functional outcomes and lower rates of symptomatic intracranial hemorrhage. The systematic review indicates that the greater aspiration force generated by larger catheter lumens allows for more complete clot engagement, potentially increasing the likelihood of first-pass success compared to smaller bore devices.

The clinical significance extends beyond procedural metrics. According to the World Health Organization, stroke is the second leading cause of death globally, responsible for approximately 6.5 million deaths annually. Every minute of delayed recanalization is associated with the loss of roughly 1.9 million neurons, making procedural efficiency critically important. By potentially reducing the number of passes required and shortening overall procedure time, super large bore catheters could contribute to improved neurological outcomes. However, the review also notes that larger devices must be balanced against considerations such as vessel navigability, particularly in tortuous anatomy, and the risk of vasospasm.

How Will This Impact Future Stroke Treatment Protocols?

The evolution of thrombectomy technology has been rapid since the original five randomized controlled trials published in 2015 established the procedure's efficacy. Current American Heart Association and American Stroke Association guidelines recommend mechanical thrombectomy for eligible patients with large vessel occlusion stroke, but they do not specify a preferred device type or technique. The systematic review's findings add to a growing body of evidence that may eventually influence device selection recommendations in future guideline updates.

Several manufacturers now offer catheters in the super large bore category, and ongoing competition is driving further innovation in catheter design, including improvements in trackability, flexibility, and distal access. Experts in the field note that while the evidence is promising, most studies to date are observational or retrospective. Prospective randomized controlled trials directly comparing super large bore catheters to standard devices will be essential to establish definitive clinical superiority and inform evidence-based treatment protocols.